BioNTech stock jumped Tuesday after the company projected $11.5 billion in Covid vaccine sales based on its existing contracts. The company expects to make 2.5 billion doses in 2021.
BioNTech Stock Pops As Company Projects $11.5 Billion In Covid Vaccine Sales
2021-03-30T14:09:02-04:00March 30th, 2021|